General Information of Drug (ID: DMVRN0I)

Drug Name
1-(piperidin-3-ylmethyl)pyridin-2(1H)-one
Synonyms
1-(piperidin-3-ylmethyl)pyridin-2(1H)-one; 820231-74-1; 2(1H)-Pyridinone, 1-(3-piperidinylmethyl)-; CHEMBL205267; SCHEMBL2503319; CTK3E3069; DTXSID80658785; CRXGPVZZFUWGAF-UHFFFAOYSA-N; AKOS010944098; 1-Piperidin-3-ylmethyl-1H-pyridin-2-one; 1-[(Piperidin-3-yl)methyl]pyridin-2(1H)-one
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 192.26
Logarithm of the Partition Coefficient (xlogp) 0.7
Rotatable Bond Count (rotbonds) 2
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 2
Chemical Identifiers
Formula
C11H16N2O
IUPAC Name
1-(piperidin-3-ylmethyl)pyridin-2-one
Canonical SMILES
C1CC(CNC1)CN2C=CC=CC2=O
InChI
InChI=1S/C11H16N2O/c14-11-5-1-2-7-13(11)9-10-4-3-6-12-8-10/h1-2,5,7,10,12H,3-4,6,8-9H2
InChIKey
CRXGPVZZFUWGAF-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
44410533
CAS Number
820231-74-1
TTD ID
D0C7GB

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Neuronal acetylcholine receptor alpha-2 (CHRNA2) TTF4E0J ACHA2_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity. J Med Chem. 2006 May 4;49(9):2673-6.